FDA Investigator: Marcelo O. Mangalindan
- Marcelo O. Mangalindan first started conducting FDA inspections in 2002, with the last inspection in 2018. Over that time, Marcelo O. Mangalindan has conducted 194 inspections at 180 companies across 179 sites.
Get Marcelo Mangalindan's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Joel D. Cooper, M.D, Philadelphia | September 2017
Available Now - $199
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Stephan A. Grupp, M.D., Ph.D, Philadelphia | 2017
Available Now - $199
Marcelo O. Mangalindan
Biologic Form 483
FDA 483 Teva Pharmaceuticals, Horsham | June 2016
Available Now - $199
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Digestive Care, Bethlehem | September 2015
Available Now - $199
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Polysciences, Warrington | April 2015
Available Now - $199
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Packaging Coordinators, Philadelphia | March 2014
Available Now - $199
Marcelo O. Mangalindan
Animal Drugs & Feed Form 483
FDA 483 Tris Pharma Inc., Monmouth Junction | 2018
Out-of-stock
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Giacomina Massaro-Giordano M.D., Philadelphia | 2018
Out-of-stock
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Pascal M. Jabbour, MD, Philadelphia | 2017
Out-of-stock
Marcelo O. Mangalindan
Medical Devices & Rad Health Form 483
FDA 483 Janssen Research & Development, LLC, Spring House | 2017
Out-of-stock
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Susan C. Taylor, MD, Philadelphia | 2017
Out-of-stock
Marcelo O. Mangalindan
Medical Devices & Rad Health Form 483
FDA 483 OPTINOSE US INC, Yardley | 2017
Out-of-stock
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Joseph A. Abboud, M.D., Philadelphia | 2017
Out-of-stock
Marcelo O. Mangalindan
Medical Devices & Rad Health Form 483
FDA 483 Charu Aggarwal, MD, MPH, Hematology-Oncology Division, Philadelphia | 2017
Out-of-stock
Marcelo O. Mangalindan
Human Drug Form 483
FDA 483 Merck & Co., Inc., North Wales | 2016
Out-of-stock
Marcelo O. Mangalindan
Human Drug Form 483
Co-Investigators (32)
- Rochelle L. Cross, FDA Investigator
- Craig D. Zagata, FDA Investigator
- Mark J. Seaton, FDA Investigator
- Ching-Jey G. Chang, FDA Investigator
- Tahseen Mirza, FDA Investigator
- Michael L. Casner, FDA Investigator
- Deborah J. Parris, FDA Investigator
- James P. McEvoy, FDA Investigator
- Michael J. Nerz, FDA Investigator
- Kendra L. Brooks, FDA Investigator
- Gayle S. Lawson, FDA Investigator
- Kinh Q. Mac, FDA Investigator
- Judith A. Jones, FDA Investigator
- Michael Rosner, FDA Investigator
- Devon Jenkins, FDA Investigator
- Byungja E. Marciante, FDA Investigator
- Amy M. Cramer, FDA Investigator
- Russell J. Glapion, FDA Investigator
- Raymond L. Cheung, FDA Investigator
- William W. Dotts, FDA Investigator
- Loretta Nemchik, FDA Investigator
- Stephanie Durso, FDA Investigator
- Shirley H. Isbill, FDA Investigator
- Regina T. Brown, FDA Investigator
- Dawn L. Wydner, FDA Investigator
- Jean M. Kelahan, FDA Investigator
- Edward Oshaughnessy, FDA Investigator
- Marjorie D. Schultz, FDA Investigator
- Sinai Davis, FDA Investigator
- Charles I. Ahn, FDA Investigator
- Laishan L. Lam, FDA Investigator
- Keith M. Reilly, FDA Investigator